Chronic Plaque Psoriasis Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Chronic Plaque Psoriasis Market is segmented By Drug Class (Biologics, Small Molecule Drugs), By Route of Administration (Injectable, Oral, Topical), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD Billion) for the above-mentioned segments.

Chronic Plaque Psoriasis Market is segmented By Drug Class (Biologics, Small Molecule Drugs), By Route of Administration (Injectable, Oral, Topical), ....

Chronic Plaque Psoriasis Market Size

Market Size in USD

CAGR6.5%

Study Period	2024 - 2031
Base Year of Estimation	2023
CAGR	6.5%
Market Concentration	High
Major Players	Novartis AG, Eli Lilly and Company, AbbVie Inc., Johnson & Johnson (Janssen Biotech), Amgen Inc.

*Disclaimer: Major players are listed in no particular order.

*Source: Coherent Market Insights

Want to purchase customized report?
please let us know !

Chronic Plaque Psoriasis Market Analysis

The chronic plaque psoriasis market is estimated to be valued at USD 22.9 Bn in 2024 and is expected to reach USD 35.6 Bn by 2031, growing at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031. The rising prevalence of autoimmune and inflammatory diseases is expected to boost the number of new patients entering the market.

Chronic Plaque Psoriasis Market Report Snapshots

Buy Now